Seres Therapeutics MCRB
NASDAQ MCRB
$2.09 -0.04 (-1.88%)
At close: Oct 23, 2026 · 4:00 PM EDT

Seres Therapeutics (MCRB) Income from Discontinued Operations (2023 - 2024)

Updated

Seres Therapeutics (MCRB) posted Income from Discontinued Operations of $125.91 million for FY2024, up 64.8% from $76.41 million in FY2023.

Analysis

Seres Therapeutics (MCRB) Income from Discontinued Operations (2023 - 2024) Analysis & Trends

  • Business Quant data shows MCRB's Income from Discontinued Operations at $76.41 million in FY2023 and -$66.58 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 8.00 Mn
10 Seres Therapeutics 20.54 Mn -118.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 139.81 Mn
Jun 30, 2024 -6.67 Mn
Mar 31, 2024 -7.23 Mn
Dec 31, 2023 -6.53 Mn
Sep 30, 2023 -6.84 Mn
API Access

Seres Therapeutics Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=MCRB&period=max&api_key=YOUR_API_KEY